| 1 |
34672113 | Clinical and Preclinical Evidence for Roles of Soluble Epoxide Hydrolase in Osteoarthritis Knee Pain. | 2022 Apr |
1 |
| 2 |
33418110 | Endothelial Nox4 dysfunction aggravates atherosclerosis by inducing endoplasmic reticulum stress and soluble epoxide hydrolase. | 2021 Feb 20 |
1 |
| 3 |
33559150 | Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model. | 2021 Sep |
1 |
| 4 |
33864813 | Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney. | 2021 Jan-Jun |
1 |
| 5 |
34218083 | Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis. | 2021 Nov 5 |
5 |
| 6 |
34592333 | Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice. | 2021 Nov |
1 |
| 7 |
34601968 | Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation. | 2021 Nov |
1 |
| 8 |
32787085 | 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis. | 2020 Sep 10 |
1 |
| 9 |
32973044 | 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease. | 2020 Oct 14 |
2 |
| 10 |
33298560 | An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease. | 2020 Dec 9 |
1 |
| 11 |
29803731 | Adamantyl thioureas as soluble epoxide hydrolase inhibitors. | 2018 Jul 15 |
1 |
| 12 |
28485854 | Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. | 2017 Jul |
1 |
| 13 |
26727266 | Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice. | 2016 |
1 |
| 14 |
24035338 | Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension. | 2013 Nov 1 |
3 |
| 15 |
22739108 | Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. | 2012 Sep 1 |
1 |
| 16 |
15994227 | Soluble epoxide hydrolase is a therapeutic target for acute inflammation. | 2005 Jul 12 |
1 |
| 17 |
12620084 | QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds. | 2003 Mar 13 |
2 |
| 18 |
10430859 | Potent urea and carbamate inhibitors of soluble epoxide hydrolases. | 1999 Aug 3 |
1 |